In this way, our current study also confirms our previous observations regarding the efficacy of D + C treatment not only in the highly PD-L1-expressing cell line HCC-44 but also in the A549 cell line with low PD-L1 expression [8]. Here, CD274 is linked to hepatocellular carcinoma.